Erythropoietin Drugs Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Erythropoietin 
Drugs Market Research 
and Forecast Report 
2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
Acco r d ing  t o  t he  l a t es t  r epo r t  b y  I M ARC G r ou p ,  t i t l e d  " Ery t hro po i e t i n  Dr ugs  
M ar ke t :  G l ob a l  I ndu st ry  T rend s ,  Shar e ,  S i ze ,  G row t h ,  O pp or t u n i t y  and  Fo rec as t  
2024 - 203 2 , "  t he  g lob a l  e r y t h r o po ie t i n  d r ug s  m a r ke t  s i ze  r e ached  US$  11 . 0  B i l l i on  i n  
2023 .
E r y t h r opo ie t i n  ( EP O )  i s  a  h o r m o ne  p r odu ced  na t u r a l l y  by  k i dneys  t o  s t im u la t e  t he  
Report p r od uc t i on  o f  r ed  b lood  ce l l s  ( R BCs)  i n  t he  bo dy .  I t s  de f i c i en cy  o r  e xcess  l e ads  t o  
seve r e  m ed ic a l  co nd i t i o ns ,  such  as  lo w  h em o g lob in  l eve ls  an d  k id ney  d i seas es .  E PO  
Highlight and d r ug s ,  a l so  known  as  hem a t op o ie t i c ,  a r e  i n jec t ab le  d r ugs  u sed  t o  cu r e  an em ia  a nd  i nc r ease  RBC p r odu c t i on .  
They  a r e  w ide l y  u sed  t o  t r ea t  anem ic  con d i t i on s  caus ed  by  c h r on i c  r ena l  d i seas e ,  
Description can ce r  t r ea t m en t ,  m ye lo dysp la s ia ,  m ed ic ine  s ide  e f f e c t s ,  and  s u r ge r y .  T hey  a l so  
he lp  r educ e  i n f ec t i on s  i n  ac qu i r ed  im m une  de f i c i en cy  syn d r om e  ( A I DS )  and  p r e -
ope r a t i ve  b loo d  t r ans f us ion .  EPO  d r u gs  m im ic  t he  na t u r a l l y  occu r r i ng  e r y t h r opo ie t i n  
and  s t im u la t e  t he  bone  m ar r ow  t o  p r o duc e  m or e  RB Cs .
Reque st  f o r  a  PDF  sam pl e  o f  t h i s  re por t :  
h t t p s : / / www. im ar c g r ou p . com / e r y t h r op o ie t in - d r ug s - m ar ke t / r eq ues t sam p le
Report Description
G l o b a l  E r y t h r o p o i e t i n  D r u g s  M a r k e t  T r e n d s :
T h e  w i d e s p r e a d  p r e v a l e n c e  o f  c h r o n i c  d i s e a s e s ,  s u c h  a s  c a n c e r ,  A I D S ,  a n d  k i d n e y  p r o b l e m s ,  i s  o n e  o f  t h e  p r i m a r y  f a c t o r s  d r i v i n g  t h e  m a r k e t  
g r o w t h .  E P O  d r u g s  a r e  w i d e l y  u s e d  t o  t r e a t  a n e m i c  c o n d i t i o n s  i n d u c e d  b y  e n d - s t a g e  r e n a l  d i s e a s e  ( E S R D ) ,  a n t i r e t r o v i r a l  t r e a t m e n t s  ( A R T ) ,  
c h e m o t h e r a p y ,  r a d i o t h e r a p y ,  a n d  o t h e r  c a n c e r  t r e a t m e n t s .  I n  a d d i t i o n  t o  t h i s ,  r i s i n g  p r o d u c t  u t i l i z a t i o n  t o  t r e a t  c r i t i c a l l y  i l l  p a t i e n t s  o w i n g  t o  i t s  
a n t i - i s c h e m i c ,  a n t i - a p o p t o t i c ,  a n d  r e g e n e r a t i v e  e f f e c t s  i n  v a r i o u s  t i s s u e s ,  s u c h  a s  l u n g s ,  k i d n e y s ,  n e r v o u s  s y s t e m ,  p a n c r e a s ,  a n d  r e t i n a ,  i s  
a c t i n g  a s  a n o t h e r  g r o w t h - i n d u c i n g  f a c t o r .  F u r t h e r m o r e ,  t h e  r a p i d  c o m m e r c i a l i z a t i o n  o f  h i g h l y  e f f i c i e n t  b i o s i m i l a r s ,  w h i c h  a r e  e a s y  t o  s w i t c h ,  
c o s t - e f f e c t i v e ,  a n d  r e q u i r e  l e s s  a p p r o v a l  t i m e ,  i s  p r o v i d i n g  a n  i m p e t u s  t o  t h e  m a r k e t  g r o w t h .  I n  l i n e  w i t h  t h i s ,  t h e  w i d e s p r e a d  p r o d u c t  
a p p l i c a t i o n  i n  c h e m o t h e r a p y  c y c l e s ,  a l o n g  w i t h  t h e  i n c r e a s i n g  i n c i d e n c e s  o f  e n d - s t a g e  r e n a l  d i s e a s e s  ( d i a l y s i s ) ,  i s  f a v o r i n g  t h e  m a r k e t  g r o w t h .  
A d d i t i o n a l l y ,  t h e  r e c e n t  r e p u r p o s i n g  o f  E P O  d r u g s  f o r  t r e a t i n g  d i a b e t e s  m e l l i t u s  ( D M )  d u e  t o  i t s  c y t o p r o t e c t i v e  e f f e c t  t h a t  e n h a n c e s  c a r d i a c  
f u n c t i o n ,  r e d u c e s  f a t i g u e ,  a n d  i m p r o v e s  c o g n i t i o n  i n  D M  p a t i e n t s  i s  p o s i t i v e l y  i n f l u e n c i n g  t h e  m a r k e t  g r o w t h .  M o r e o v e r ,  t h e  i m p l e m e n t a t i o n  o f  
v a r i o u s  g o v e r n m e n t  i n i t i a t i v e s  t o  i n c e n t i v i z e  r e s e a r c h  o n  c h r o n i c  d i s e a s e s  t h r o u g h  g r a n t s ,  d r u g  e x c l u s i v i t y ,  f e e  w a i v e r s ,  a n d  t a x  c r e d i t s  i s  
p r o p e l l i n g  t h e  m a r k e t  g r o w t h .  O t h e r  f a c t o r s ,  i n c l u d i n g  r i s i n g  a w a r e n e s s  r e g a r d i n g  t h e  b e n e f i t s  o f  E P O  t h e r a p e u t i c s ,  t h e  i n c r e a s i n g  g e r i a t r i c  
p o p u l a t i o n  i n  n e e d  o f  s u r g i c a l  p r o c e d u r e s ,  a n d  r i s i n g  s t r a t e g i c  c o l l a b o r a t i o n s  a m o n g  d r u g  m a n u f a c t u r e r s  d u e  t o  h i g h  r e t u r n  o n  i n v e s t m e n t  
( R O I ) ,  a r e  a n t i c i p a t e d  t o  d r i v e  t h e  m a r k e t  g r o w t h .
L o o k i n g  f o r w a r d ,  t h e  m a r k e t  v a l u e  i s  e x p e c t e d  t o  r e a c h  U S $  1 7 . 3  B i l l i o n  b y  2 0 3 2 ,  e x h i b i t i n g  a  C A G R  o f  5 %  d u r i n g  2 0 2 4 - 2 0 3 2 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / e r y t h r o p o i e t i n - d r u g s - m a r k e t
Drug Class Insights:
• Biologics
• Biosimi lars
 
Product Type Insights:
• Epoetin-al fa
• Epoetin-beta
Report 
• Darbepoetin-al fa
Segmentation • Others
Application Insights:
• Hematology
• Kidney Disorder
• Cancer
• Others
End-User Insights:
• Hospitals
• Homecare
• Specialty Cl inics
• Others
Report Regional Insights:
Segmentation • North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Amgen Inc.
• Biocon Limited
• Dr. Reddy’s Laboratories Ltd.
• F. Hoff mann-La Roche AG
Competitive 
• Intas Pharmaceuticals Ltd.
Landscape • Johnson & Johnson
with Key • LG Chem Ltd.
• Pfi zer Inc.
Players
• Sun Pharmaceutical  Industries Limited
• Teva Pharmaceutical  Industr ies Ltd.
How big is the global erythropoietin drugs market?
What is the expected growth rate of the global 
erythropoietin drugs market during 2024-2032?
Key 
Questions What are the key factors driving the global erythropoietin drugs market?
Answered in 
What has been the impact of COVID-19 on the 
the Report global erythropoietin drugs market?
What is the breakup of the global erythropoietin 
drugs market based on the drug class?
What is the breakup of the global erythropoietin 
drugs market based on the product type?
What is the breakup of the global erythropoietin 
drugs market based on the application?
What is the breakup of the global erythropoietin 
drugs market based on the end-user?
Key 
Questions What are the key regions in the global erythropoietin drugs market?
Answered in 
the Report Who are the key players/companies in the global erythropoietin drugs market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  E r y t h r o p o i e t i n  D r u g s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  D r u g  C l a s s
    6 . 1     B i o l o g i c s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     B i o s i m i l a r s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  P r o d u c t  T y p e
    7 . 1     E p o e t i n - a l f a
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     E p o e t i n - b e t a
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     D a r b e p o e t i n - a l f a
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     O t h e r s
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     H e m a t o l o g y
Table of         8 . 1 . 1  M a r k e t  T r e n d s        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     K i d n e y  D i s o r d e r
        8 . 2 . 1  M a r k e t  T r e n d s
Contents         8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     C a n c e r
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     O t h e r s
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  E n d  U s e r
    9 . 1     H o s p i t a l s
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t
    9 . 2     H o m e c a r e
        9 . 2 . 1  M a r k e t  T r e n d s
        9 . 2 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /e ry th ro po i e t i n -d rugs -m a rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: